Skip to main navigation Skip to search Skip to main content

Amiloidosis cardiaca secundaria a macroglobulinemia de waldenström

  • Lizbeth Lachira-Yparraguirre
  • , Ali Al-Kassab-córdova
  • , Edgar Quispe-Silvestre
  • , Daniel Enriquez-Vera

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Waldenström's macroglobulinemia is a hematological neoplasm belonging to the group of monoclonal gammopathies, which includes systemic symptoms and those related to an increase in M paraprotein. Objective: To describe a case of cardiac amyloidosis associated with macroglobulinemia. Clinical case: Male patient who was admitted for asthenia, dysphonia, and who, during his evolution, developed progressive dyspnea, heart failure and pleural effusion. Additionally, echocardiography showed myocardial granular pattern, while pleural biopsy was positive for Congo red staining. Subsequently, he received treatment with bortezomib, dexamethasone and rituximab, with favorable evolution. Conclusions: In this disease, early diagnosis is an important advantage for survival. Therefore, its management is palliative of cardiac manifestations. The present case shows a diagnostic challenge, in which the less frequent etiologies of heart failure must be taken into account.

Translated title of the contributionCardiac amyloidosis secondary to waldenström macroglobulinemia
Original languageSpanish
Article numbere1202
Pages (from-to)1-11
Number of pages11
JournalRevista Cubana de Hematologia, Inmunologia y Hemoterapia
Volume36
Issue number3
StatePublished - 1 Jan 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Amiloidosis cardiaca secundaria a macroglobulinemia de waldenström'. Together they form a unique fingerprint.

Cite this